跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14,491 条关于
“Renal Osteodystrophy”
全部
14,491
临床试验
12,601
药物
108
机构
32
资讯
1,750
2年前
Unicycive Submits NDA to FDA for Oxylanthanum Carbonate to Treat Hyperphosphatemia in CKD Patients on Dialysis
去年
FDA Accepts Unicycive's Oxylanthanum Carbonate (OLC) Application for Hyperphosphatemia Treatment
去年
FDA Accepts Unicycive's NDA for Oxylanthanum Carbonate to Treat Hyperphosphatemia in CKD Patients on Dialysis
去年
Unicycive's OLC Receives FDA Acceptance for Hyperphosphatemia NDA
去年
Alebund's AP301 Meets Primary Endpoint in Phase 3 Trial for Hyperphosphatemia in Dialysis Patients
3个月前
CAR T Cell Therapy Enables Kidney Transplants in Highly Sensitized Patients in First-of-Its-Kind Trial
去年
Autologous CD34+ Cell Therapy Shows Promise in Improving Renal Function in Progressive CKD
2年前
Advances and Challenges in Renal Cell Carcinoma Treatment
去年
Roivios' JuxtaFlow Renal Assist Device Receives FDA IDE Approval for Pivotal Trial
去年
Ultrasound Renal Denervation: A New Hope for Resistant Hypertension
第 1 页,共 175 页
上一页
下一页